Fei Wang
机构:Hebei Medical University, Binzhou Medical University, University of Electronic Science and Technology of China, Shandong University of Aeronautics, Xinjiang Medical University, Capital Medical University, Jilin University, Nantong University, Hong Kong University of Science and Technology, Peking University, Beijing Chao-Yang Hospital, Capital Medical University, First Affiliated Hospital of Xinjiang Medical University, Beijing Jishuitan Hospital, Affiliated Hospital of Nantong University, First Affiliated Hospital of Sichuan Medical University, Third Hospital of Hebei Medical University, Quzhou City People's Hospital, Hospital of Hebei Province, Quzhou College of Technology, Xi'an Honghui Hospital, Shandong Tumor Hospital, JiangSu Armed Police General Hospital, Jiangyin People's Hospital, Xi'an Medical University, Nanjing Drum Tower Hospital, Second People's Hospital of NanTong, Weifang People's Hospital, Quzhou University, Yancheng Third People's Hospital, Zhejiang Energy Group (China), Zhejiang Center for Disease Control and Prevention, Second Affiliated Hospital of Nanjing Medical University, First Hospital of China Medical University, Xijing Hospital, Shandong First Medical University, Hubei University, Nanjing Medical University, Xi'an Jiaotong University, University of Hong Kong, China Medical University, University of South China, Air Force Medical University · ORCID:0000-0002-5670-1944
发表论文 322 篇 · 总被引 4895 次 · h-index 33
代表论文
- Somatostatin receptor-targeted polymeric nanoplatform for efficient CRISPR/Cas9 gene editing to enhance synergistic hepatocellular carcinoma therapy (2025 · Journal of Nanobiotechnology · 被引 14)
- 20(S)-ginsenoside Rg3 suppresses gastric cancer cell proliferation by inhibiting E2F-DP dimerization (2025 · Phytomedicine · 被引 12)
- Intramolecular through-space heavy-atom effect in π-stacked MR-TADF emitters (2025 · Chem · 被引 8)
- Almonertinib inhibits liver cancer progression by triggering autophagy-dependent ferroptosis through inhibition of the PI3K/Akt1/mTOR pathway (2025 · Biochemical Pharmacology · 被引 5)
- Recent advance of KRAS-G12C inhibitors for cancer therapy (2025 · European Journal of Medicinal Chemistry · 被引 5)
- Association of inactive pulmonary tuberculosis lesions with the risk of active disease development in the elderly: a population-based retrospective study (2025 · ERJ Open Research · 被引 5)